SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-067294
Filing Date
2023-06-02
Accepted
2023-06-02 08:55:08
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2317534d1_s3.htm S-3 365229
2 EXHIBIT 4.1 tm2317534d1_ex4-1.htm EX-4.1 11974
3 EXHIBIT 4.4 tm2317534d1_ex4-4.htm EX-4.4 347936
4 EXHIBIT 4.5 tm2317534d1_ex4-5.htm EX-4.5 377187
5 EXHIBIT 5.1 tm2317534d1_ex5-1.htm EX-5.1 42817
6 EXHIBIT 23.1 tm2317534d1_ex23-1.htm EX-23.1 4934
7 EX-FILING FEES tm2317534d1_ex-filingfees.htm EX-FILING FEES 69367
8 GRAPHIC tm2317534d1_ex4-1img01.jpg GRAPHIC 147244
9 GRAPHIC tm2317534d1_ex4-1img02.jpg GRAPHIC 193929
10 GRAPHIC tm2317534d1_s3img003.jpg GRAPHIC 7099
11 GRAPHIC tm2317534d1_s3img01.jpg GRAPHIC 6149
12 GRAPHIC tm2317534d1_s3img02.jpg GRAPHIC 3816
13 GRAPHIC tm2317534d1_ex5-1img001.jpg GRAPHIC 2277
14 GRAPHIC tm2317534d1_ex5-1img002.jpg GRAPHIC 3818
15 GRAPHIC tm2317534d1_ex23-1img01.jpg GRAPHIC 4229
  Complete submission text file 0001104659-23-067294.txt   1729290
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272359 | Film No.: 23986868
SIC: 2834 Pharmaceutical Preparations